Expression, Identification and Characterize of CD25-Binding Epitope Modified Human IL-2 in Pichia pastoris

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Indian Journal of Microbiology

• Publication date

  2013-02-07

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1007/s12088-013-0366-3PMID 24426123PMCID PMC3689400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-2 and type 1 diabetes: new therapeutic perspectives.

  2012cited by this paper
• Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.

  2012cited by this paper
• Suppressive effects of aluminum trichloride on the T lymphocyte immune function of rats.

  2012cited by this paper
• Application of IL-2 therapy to target T regulatory cell function.

  2012cited by this paper
• Large-scale production, purification and bioactivity assay of recombinant human interleukin-6 in the methylotrophic yeast Pichia pastoris.

  2011cited by this paper
• Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

  2010cited by this paper
• Expression, purification, and characterization of a functional mutant recombinant human interleukin-2.

  2010cited by this paper
• The proteolytic systems and heterologous proteins degradation in the methylotrophic yeastPichia pastoris

  2007cited by this paper
• In vivo CD4+ T-cell up-regulation and high dose side effects of refolded duck interleukin-2.

  2006cited by this paper
• Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease

  2006influential reference
• Heterologous protein production using the Pichia pastoris expression system

  2005cited by this paper
• Application of IL-2 and other cytokines in renal cancer

  2004influential reference
• Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo

  2003cited by this paper
• Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

  2003cited by this paper
• Pretreatment with interleukin-2 modulates peri-operative immuno-dysfunction in patients with renal cell carcinoma.

  2002cited by this paper
• Managing toxicities of high-dose interleukin-2.

  2002cited by this paper
• Comparative tissue distribution of 125I- and U-14C-labeled recombinant human interleukin-2 in the rat.

  1992cited by this paper
• Pharmacokinetics of recombinant interleukin 2 in humans.

  1990cited by this paper

• High-level Expression of a Manganese Superoxide Dismutase (PoMn-SOD) from Pleurotus ostreatus in Pichia pastoris

  2014cites this paper